This page contains information about prescription medications. According to the Russian regulatory requirements, this information can be available only for medical or pharmaceutical stuff.

Do you confirm that you are a medical of pharmaceutical specialist?

Report an adverse reaction
Main pageOur products


Diaskintest® belongs to the IGRA group of tests, the latter being the most promising direction in the diagnosis of infectious diseases.

Indications for use

Diaskintest® is highly specific and does not give positive reactions in BCG-vaccinated children. Diaskintest allows you to identify only a group of people with an active tuberculosis process and with a high risk of developing tuberculosis, reducing to zero the false positive results inherent in the Mantoux test.

Since 2009, more than 20 million samples using Diaskintest® have been supplied in the Russian Federation and CIS countries. As a result of the use of the drug, early diagnosis of tuberculosis in children has improved. The drug is included in the methodological recommendations of the Ministry of Health and is used in Russia for mass diagnosis of tuberculosis.

In 2012, Diaskintest® was awarded the Russian Government Prize in the field of science and technology, and in 2014 - the Galien Prix, an international award in the field of biopharmaceuticals.

Recently, Diaskintest® has included in the list of drugs recommended by the World Health Organization for the diagnosis of tuberculosis.

ЛСР-006435/08 от 11.08.2008